Dual targeting of mitochondrial unfolded protein response (UPRmt) and BCL2 in acute myeloid leukemia

Jo Ishizawa

Presentation information

Oral Session

Oral Session 2-11B AML: Novel therapeutic targets

Sat. Oct 13, 2018 10:10 AM - 11:10 AM No.11 (Osaka International Convention Center, 10F 1004-5)

Chair: Yoichi Imai (Research Hospital, The Instisute of Medical Science, The University of Tokyo, Japan)

[OS2-11B-2] Dual targeting of mitochondrial unfolded protein response (UPRmt) and BCL2 in acute myeloid leukemia

Jo Ishizawa¹, Takenobu Nii², Ran Zhao¹, Lauren Heese¹, Yuki Nishida¹, Gautam Borthakur¹, Kensuke Kojima^1,3, Joshua Allen⁴, Varun Prabhu⁴, R Eric Davis⁵, Michael Andreeff¹ (1.Dept. of Leukemia, UT MD Anderson, Houston, USA, 2.Kyushu Univ., Kyushu, Japan, 3.Div. Hematol., Resp Med, and Oncol., Saga Univ., Saga, Japan, 4.Oncoceutics, Inc., Philadelphia, USA, 5.Dept. of Lymphoma/Myeloma, UT MD Anderson, Houston, USA)

Abstract password authentication.
Password is written on a program and abstract book.